Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?

Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.

Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.

clinical practice
Image of the Day: Spinal Tap
Image of the Day: Spinal Tap
Nicoletta Lanese | Aug 29, 2019
A medical art student’s master’s project will be used to help train junior physicians to perform lumbar punctures.
Drugs, Developed
Drugs, Developed
Bob Grant | Feb 28, 2019
In an era of instant communication, we must be careful how word of new and untested treatments is shared.
General Anesthesia Causes Telltale Brain Activity Patterns
General Anesthesia Causes Telltale Brain Activity Patterns
Emery N. Brown, Francisco J. Flores | Feb 28, 2019
The drugs lead to widespread, predictable changes in brain waves that can help anesthesiologists personalize anesthesia and develop anesthetic-based treatments.
Dartmouth Professor Plagiarized His Colleague, University Says
Dartmouth Professor Plagiarized His Colleague, University Says
Jef Akst | Aug 20, 2018
H. Gilbert Welch, a health policy expert who has advocated against superfluous cancer screening, published another Dartmouth researcher’s work, according to the university administration.
Exome Sequencing Helps Crack Rare Disease Diagnosis
Exome Sequencing Helps Crack Rare Disease Diagnosis
Amanda B. Keener | Apr 30, 2018
Clinical analyses of patients’ gene sequences are helping to provide answers where none were available before.
Sequencing Genomes in the ICU Improves Outcomes
Sequencing Genomes in the ICU Improves Outcomes
Bob Grant | Oct 19, 2017
A handful of infants in a neonatal intensive care unit who were diagnosed with rare diseases using whole-genome sequencing had shorter hospital stays and better health outcomes, researchers find.
Is Medicine Ready for Clinical CRISPR?
Is Medicine Ready for Clinical CRISPR?
John Parrington | Nov 30, 2016
Using precision genome editing to treat or prevent human disease may require several leaps of faith.
Book Excerpt from <em>Redesigning Life</em>
Book Excerpt from Redesigning Life
John Parrington | Nov 30, 2016
In Chapter 8, author John Parrington explores the intersection of precision genome editing and stem cell technologies.
The Upside
The Upside
Amanda B. Keener | Aug 31, 2015
Researchers explore the benefits of hearing loss and impairment.